Clinical Study
Bevacizumab versus Ranibizumab on As-Needed Treatment Regimen for Neovascular Age-Related Macular Degeneration in Turkish Patients
| ā | Bevacizumab group ( patients) | Ranibizumab group ( patients) | P value |
| Punctuate keratitis | 10 (12.6%) | 11 (14.8%) | 0.7 | Subconjunctival Hemorrhage | 7 (8.8%) | 8 (10.8%) | 0.5 | Mild transient Anterior uveitis | 5 (6.3%) | 2 (2.7%) | 0.1 |
|
|